323 related articles for article (PubMed ID: 24133029)
1. Involvement of HMGB1 mediated signalling pathway in diabetic retinopathy: evidence from type 2 diabetic rats and ARPE-19 cells under diabetic condition.
Chen XL; Zhang XD; Li YY; Chen XM; Tang DR; Ran RJ
Br J Ophthalmol; 2013 Dec; 97(12):1598-603. PubMed ID: 24133029
[TBL] [Abstract][Full Text] [Related]
2. High-mobility group box-1 protein activates inflammatory signaling pathway components and disrupts retinal vascular-barrier in the diabetic retina.
Mohammad G; Siddiquei MM; Othman A; Al-Shabrawey M; Abu El-Asrar AM
Exp Eye Res; 2013 Feb; 107():101-9. PubMed ID: 23261684
[TBL] [Abstract][Full Text] [Related]
3. HMGB1 siRNA can reduce damage to retinal cells induced by high glucose in vitro and in vivo.
Jiang S; Chen X
Drug Des Devel Ther; 2017; 11():783-795. PubMed ID: 28352154
[TBL] [Abstract][Full Text] [Related]
4. Extract of Polygonum cuspidatum Attenuates Diabetic Retinopathy by Inhibiting the High-Mobility Group Box-1 (HMGB1) Signaling Pathway in Streptozotocin-Induced Diabetic Rats.
Sohn E; Kim J; Kim CS; Lee YM; Kim JS
Nutrients; 2016 Mar; 8(3):140. PubMed ID: 26950148
[TBL] [Abstract][Full Text] [Related]
5. Cytoplasmic translocation of high-mobility group box-1 protein is induced by diabetes and high glucose in retinal pericytes.
Kim J; Kim CS; Sohn E; Kim JS
Mol Med Rep; 2016 Oct; 14(4):3655-61. PubMed ID: 27599553
[TBL] [Abstract][Full Text] [Related]
6. The role of Toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in proximal tubules.
Mudaliar H; Pollock C; Komala MG; Chadban S; Wu H; Panchapakesan U
Am J Physiol Renal Physiol; 2013 Jul; 305(2):F143-54. PubMed ID: 23576640
[TBL] [Abstract][Full Text] [Related]
7. High-Mobility Group Box-1 Protein Mediates the Regulation of Signal Transducer and Activator of Transcription-3 in the Diabetic Retina and in Human Retinal Müller Cells.
Mohammad G; Jomar D; Siddiquei MM; Alam K; Abu El-Asrar AM
Ophthalmic Res; 2017; 57(3):150-160. PubMed ID: 27560926
[TBL] [Abstract][Full Text] [Related]
8. HMGB1 upregulates NF-kB by inhibiting IKB-α and associates with diabetic retinopathy.
Liang WJ; Yang HW; Liu HN; Qian W; Chen XL
Life Sci; 2020 Jan; 241():117146. PubMed ID: 31816325
[TBL] [Abstract][Full Text] [Related]
9. The role of high-mobility group box-1 protein in the development of diabetic nephropathy.
Kim J; Sohn E; Kim CS; Jo K; Kim JS
Am J Nephrol; 2011; 33(6):524-9. PubMed ID: 21606643
[TBL] [Abstract][Full Text] [Related]
10. High mobility group B1 up-regulates angiogenic and fibrogenic factors in human retinal pigment epithelial ARPE-19 cells.
Chang YC; Lin CW; Hsieh MC; Wu HJ; Wu WS; Wu WC; Kao YH
Cell Signal; 2017 Dec; 40():248-257. PubMed ID: 28970183
[TBL] [Abstract][Full Text] [Related]
11. High-Mobility Group Box-1 Modulates the Expression of Inflammatory and Angiogenic Signaling Pathways in Diabetic Retina.
Abu El-Asrar AM; Mohammad G; Nawaz MI; Siddiquei MM
Curr Eye Res; 2015; 40(11):1141-52. PubMed ID: 25495026
[TBL] [Abstract][Full Text] [Related]
12. High glucose and oxidative/nitrosative stress conditions induce apoptosis in retinal endothelial cells by a caspase-independent pathway.
Leal EC; Aveleira CA; Castilho AF; Serra AM; Baptista FI; Hosoya K; Forrester JV; Ambrósio AF
Exp Eye Res; 2009 May; 88(5):983-91. PubMed ID: 19146853
[TBL] [Abstract][Full Text] [Related]
13. The role of high mobility group box 1 (HMGB-1) in the diabetic retinopathy inflammation and apoptosis.
Yu Y; Yang L; Lv J; Huang X; Yi J; Pei C; Shao Y
Int J Clin Exp Pathol; 2015; 8(6):6807-13. PubMed ID: 26261566
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor and its receptors in control and diabetic rat eyes.
Gilbert RE; Vranes D; Berka JL; Kelly DJ; Cox A; Wu LL; Stacker SA; Cooper ME
Lab Invest; 1998 Aug; 78(8):1017-27. PubMed ID: 9714188
[TBL] [Abstract][Full Text] [Related]
15. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
Nagai N; Izumi-Nagai K; Oike Y; Koto T; Satofuka S; Ozawa Y; Yamashiro K; Inoue M; Tsubota K; Umezawa K; Ishida S
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226
[TBL] [Abstract][Full Text] [Related]
16. Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response.
Cui B; Sun JH; Xiang FF; Liu L; Li WJ
Exp Eye Res; 2012 May; 98():37-43. PubMed ID: 22449442
[TBL] [Abstract][Full Text] [Related]
17. High glucose-induced proteome alterations in retinal pigmented epithelium cells and its possible relevance to diabetic retinopathy.
Chen YH; Chen JY; Chen YW; Lin ST; Chan HL
Mol Biosyst; 2012 Oct; 8(12):3107-24. PubMed ID: 23051786
[TBL] [Abstract][Full Text] [Related]
18. Upregulated VEGF and Robo4 correlate with the reduction of miR-15a in the development of diabetic retinopathy.
Gong Q; Li F; Xie J; Su G
Endocrine; 2019 Jul; 65(1):35-45. PubMed ID: 30980286
[TBL] [Abstract][Full Text] [Related]
19. Tanshinone II A down-regulates HMGB1, RAGE, TLR4, NF-kappaB expression, ameliorates BBB permeability and endothelial cell function, and protects rat brains against focal ischemia.
Wang L; Zhang X; Liu L; Cui L; Yang R; Li M; Du W
Brain Res; 2010 Mar; 1321():143-51. PubMed ID: 20043889
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of lycopene on HMGB1-mediated pro-inflammatory responses in both cellular and animal models.
Lee W; Ku SK; Bae JW; Bae JS
Food Chem Toxicol; 2012 Jun; 50(6):1826-33. PubMed ID: 22429818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
